Partnerships are central to Avectas. We currently have collaborations with academic, biotechnology and pharmaceutical partners. Our core objective is to enable the development of innovative next generation therapies in the area of gene editing, cell-gene therapy and immune therapy, with particular focus on oncology.
Avectas attends key scientific and commercial meetings throughout the year. See our schedule of upcoming meetings and events here. We are actively seeking licensing and development partnership opportunities with companies dedicated to bringing safe and effective advanced therapeutics to patients. Contact us today.